Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098339 · ClinicalTrials.gov registry record · NA

Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers

A NA study of Myopia and Hyperopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
53
Enrollment target
3
Study locations

NCT06098339 is a NA study of Myopia and Hyperopia that has completed, run by CooperVision. The registered enrollment target is 53 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098339, a NA study of Myopia and Hyperopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study was to compare the clinical performance of two different reusable lenses in habitual spherical soft lens wearers.

Conditions Studied

Interventions

  • DEVICE Lens A (fanfilcon A)
  • DEVICE Lens B (lotrafilcon B)

Study Locations (3)

Florida

  • Coan Eye Care - Ocoee

Pennsylvania

  • Nittany Eye Associates - State College

Ontario

  • Insight Eye Care - Waterloo

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-11-13
Est. Completion 2024-04-04
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT06098339

The ClinicalTrials.gov registry entry for NCT06098339 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (80% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Lens A (fanfilcon A) is the first listed.

NCT06098339 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Pennsylvania, Ontario.

Frequently Asked Questions

What is clinical trial NCT06098339 about?

NCT06098339 is a clinical study titled "Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers". The purpose of this study was to compare the clinical performance of two different reusable lenses in habitual spherical soft lens wearers.

What is the current status of trial NCT06098339?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2023-11-13. Estimated completion is 2024-04-04.

What conditions does trial NCT06098339 study?

This clinical trial studies the following conditions: Myopia, Hyperopia.

What interventions are being tested in trial NCT06098339?

The interventions under investigation include: Lens A (fanfilcon A) (DEVICE), Lens B (lotrafilcon B) (DEVICE).

Who is sponsoring clinical trial NCT06098339?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098339 being conducted?

This trial has 3 study locations across Florida, Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.